Robotic Orthosis Devices Market

The market for Robotic Orthosis Devices was estimated at $1.4 million in 2025; it is anticipated to increase to $3.4 million by 2030, with projections indicating growth to around $8.3 million by 2035.

Report ID:DS1801142

Author:Debadatta Patel - Senior Consultant

Published Date:February 2025

Datatree

Life Science

Medical Device

Robotic Orthosis Devices

Customization Available

Robotic Orthosis Devices - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Robotic Orthosis Devices Market Outlook

Revenue, 2025

$1.4M

Forecast, 2035

$8.3M

CAGR, 2026 - 2035

19.4%

The Robotic Orthosis Devices industry revenue is expected to be around $1.4 million in 2026 and expected to showcase growth with 19.4% CAGR between 2026 and 2035. The increasing growth prospects of the field is leading to a growing importance for robotic orthosis devices in healthcare. Healthcare providers are looking to put in place care pathways that are reliant on technology to decrease the long term effects of disability and to suit reimbursement models that are based on the value provided. Growing demand is driven by the increased occurrence of musculoskeletal and neurological disorders as well as by populations that are growing older. The significant advantages robotic rehabilitation equipment and exoskeletons have in improving the mobility of patients and the independence these patients have in their lives are also major drivers. Hospitals and rehabilitation centres are the driving force behind the adoption of robotic technologies, responsible for 75.2% of all end user uptake. They are investing heavily in this region so that they can increase the amount of therapy they can give and make their treatments more standardised. In this sector, lower limb orthoses accounted for the main source of income; however by 2025 lower limb robotic orthosis devices were selling at $0.91 billion. The strong economic case for robots in stroke rehabilitation, gait training and neuro rehabilitation reflected in the $0.91 billion sales figure for that year.

Wearable robotic systems known as robotic orthoses are advanced wearable devices which are designed to be used as a limb orthosis. This may take the form of a robotic exoskeleton for either the upper or the lower limb. Such systems enable patient movement by sensor driven, programmable actuation. A number of rehabilitation devices combine mechanical ergonomic design, real time motion feedback and intelligent control to provide repeatable training which is tailored to the task in order to help people who have musculoskeletal disorders or complex neuro motor disorders to recover. Applications of the system are found in hospital and outpatient rehabilitation clinics where robots assist with rehabilitation of patients. This is by helping patients to mobilise early, undertaking lots of physical therapy and also monitoring recovery progress closely. Assistive robotics are becoming smaller and more portable, also more adaptable through data analysis, with integration of these devices with digital health platforms becoming more widespread. The use of Robotic Orthosis Devices is expected to increase, driven by these and other factors, in hospitals worldwide.

Robotic Orthosis Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Robotic Orthosis Devices Market Outlook

Market Key Insights

The Robotic Orthosis Devices market is projected to grow from $1.4 million in 2025 to $8.3 million in 2035. This represents a CAGR of 19.4%, reflecting rising demand across Rehabilitative Therapy, Sports Performance Enhancement, and Assisted Living.
In the exoskeleton market leading companies include Ekso Bionics, Bionik Laboratories and ReWalk Robotics, driving competition among them.
The United States and Japan are expected to have the highest growth rates in the robotic orthosis devices market. Between 2025 and 2030, these countries are expected to see a compound annual growth rate of 18.6% to 27.2%.
The highest growth rate is predicted to be seen in emerging markets like Saudi Arabia, India and Brazil all of which could see growth levels ranging from 14.5% to 20.2%.
The conventional to robotic orthosis transition is expected to contribute to a $1 million increase in the growth of the robotic orthosis devices market by 2030.
Between 2025 and 2035, the market for robotic orthosis devices is forecast to expand by $6.9 million. Those involved in manufacturing the devices expect Hospitals & Home Care Application to constitute a considerable share of the market.
A 489% expansion is predicted for the robotic orthosis devices market by 2035. This forecast is based on current trends and the rapid development of technology. Additionally, the increasing incidence of neurological conditions is also expected to drive growth in the industry between 2025 and 2035.

Robotic Orthosis Devices - Country Share Analysis

Opportunities in the Robotic Orthosis Devices

The growing number of musculoskeletal disorder injuries sustained by employees of North American manufacturing firms has sparked growing interest in the use of robotic orthotic systems designed to alleviate the strain on the lower limbs. Currently, most work on lower limb robotic exoskeletons and orthotics has been confined to pilot studies in manufacturing environments such as logistics, automotive and heavy equipment assembly. The global lower limb reconstruction market is also predicted to expand from $0.91M in 2025 to $2.05M by the year 2030. The future market trend will be for forklifts which offer low operating costs, good ergonomics and high compliance with health and safety regulations.

Growth Opportunities in North America and Asia-Pacific

In North America the growth of robotic orthosis devices is driven by various factors including strong clinical evidence relating to rehabilitation robotics, well developed systems for integrating robotic exoskeletons and wearable robotics and reimbursement strategies. The health care institutions most likely to influence usage in this region will be the hospitals, which have the means to purchase a large amount of equipment, and employ a range of specialists. They will use their significant budget to purchase assistive orthotic products across a range of departments. Additionally, rehabilitation centres which focus on brain injury will drive innovation of rehabilitation techniques and ensure good outcomes through the use of data. Mid sized rehabilitation providers can reap significant benefits by adopting robotic orthosis devices within value based care contracts, in addition to increasing the size of their home based therapy programmes which are monitored remotely, and also by introducing a subscription or leasing model to reduce the financial burden on these providers. With rehabilitation robotics vendors, orthopaedic device suppliers and healthcare IT companies competing to secure a place on formularies and partnerships with healthcare systems, a provider differentiating itself through the use of AI in gait analysis, EHR integration and training offered after the sale is crucial for success.

Asia Pacifics demand for robotic orthosis devices is driven by rapid urbanisation, an increase in the rate of stroke and spinal injuries, and the governments investment in rehabilitation robotics as part of their healthy ageing and geriatric healthcare strategies. In this region, rehabilitation centres are set to be highly relevant, especially in universities and the public sector where they serve as reference points for advanced neurorehabilitation and wearable robotics technologies. Home care services are also expected to experience significant growth, driven by developments in Japan and South Korea where elderly care is generally provided at home. Potential opportunities exist in offering tiered robotic orthosis devices that are cost effective for developing markets that have limited budgets, partnering with hospitals to adapt protocols for local use and integrating services with telemedicine for physical rehabilitation to extend access to healthcare professionals in other region's. Global suppliers of robots, regional manufacturers of medical equipment and local engineering firms are forming partnerships to win contracts. This partnership success is dependent on various factors including regulatory compliance, a local support network, cultural training for patients and staff and a decrease in the workload of carers and therapists.

Market Dynamics and Supply Chain

Driver: Increasing Prevalence of Neuromuscular Disorders Combined with Rising Demand for Personalized Rehabilitation Solutions

A key driver of the robotic orthosis devices market is also the growing incidence of neuromuscular and mobility‑limiting conditions alongside heightened demand for personalized rehabilitation and therapy solutions. Aging populations and higher survival rates for conditions such as stroke, spinal cord injuries, and multiple sclerosis have also expanded the pool of patients requiring long‑term mobility assistance. Robotic orthoses provide consistent, repeatable support to strengthen weakened muscles, retrain gait patterns, and reduce secondary complications, making them indispensable in modern rehabilitative therapy programs. Separately, healthcare providers and patients are also seeking tailored therapy plans that adapt to individual progress. Advanced robotic platforms equipped with sensors, actuators, and AI‑powered algorithms enable clinicians to customize assistance levels, track metrics in real time, and adjust training protocols based on patient response. This trend toward personalized rehabilitation technology encourages adoption of adaptive exoskeletons and wearable supports in both clinical and home settings, fostering better outcomes and greater patient engagement. Together, these growth factors drive investment in robotic orthosis R&D, software integration, and broader deployment across rehabilitation facilities.

Another significant driver is also the rapid advancement in artificial intelligence‑enabled control systems and wearable sensor technologies that enhance robotic orthosis performance. Modern devices incorporate sophisticated sensors that monitor movement, muscle activation, and balance, allowing real‑time feedback and smoother, more responsive assistance. AI algorithms learn individual movement patterns to optimize support and reduce fatigue, improving comfort and efficacy. These innovations make robotic orthoses more intuitive and effective, increasing acceptance among clinicians, caregivers, and end users.

Restraint: High Cost of Robotic Orthosis Devices

The expensive nature of orthosis devices poses a major challenge in the market for them without a doubt. The advanced technology used in developing and manufacturing these devices significantly influences their pricing renderign them unaffordable for potential buyers. This delicate balance between cost and maintenance proves to be particularly tough in areas, with purchasing power. Further costs related to purchase services and updates may also discourage prospective customers thus impeding market expansion.

Opportunity: Premium Japanese Rehabilitation Centers Driving Demand for Robotic Orthosis Gait Systems and Expanding deployment of Robotic Orthosis Devices for post-stroke neurorehabilitation in aging European healthcare systems

Among Japans elite class, who are recovering from illness or injury in private rehabilitation clinics of high standing, there is a trend for patients to have intensive therapy with advanced technology and to use supportive body equipment to help their walking. The main applications of full body robotic orthosis devices that provide intense, high quality information are found in leading hospitals. These facilities however limit access to these services which leads to opportunities for private healthcare providers. Between 2025 and 2030, the global figure for full body scanners is predicted to rise from $0.1 million to $0.3 million. This would equate to the highest compound annual growth rate of 24.6%.By bringing together wearable robotics, sophisticated gait analysis and partnerships with insurers, long term high margin growth will be achieved.

Currently robotic orthosis devices are being used more than there are available in European rehabilitation of stroke victims, especially within clinics which specialise in the neurological of rehabilitation. Despite the evidence that has shown the benefits of robotic assistance in helping stroke victims regain their arm function, upper limb robotic orthoses have yet to be widely used by the medical profession. By 2030, the global market for upper limbs is forecast to reach $1.07 million. This is from $0.40 million in 2025. Companies that are integrating data driven rehabilitation robotics along with remote monitoring and AI based therapy personalisation are likely to drive adoption in public hospitals and high end outpatient facilities.

Challenge: Technological Complexity and Lack of User Training

The intricate nature of robotic orthosis devices is a factor to consider as it requires a good understanding of the technology for proper functioning to guarantee safety and efficiency measures are met consistently in their operation; however the absence of well trained staff to manage these devices may result in reduced usage and occasional mishandling situations occurring which could be detrimental in some cases as these devices require high tech knowledge that might prove challenging for users leading to potential reluctance, in their acceptance and utilization.

Supply Chain Landscape

Wearable Robotics Components

Maxon MotorBosch Sensortec

Rehabilitation Robotics Design

Bionik LaboratoriesMyomo

Robotic Orthosis Devices

ReWalk RoboticsEkso BionicsCyberdyne

End-User Applications

Clinical RehabilitationHomecareIndustrial Exoskeletons

Wearable Robotics Components

Maxon MotorBosch Sensortec

Rehabilitation Robotics Design

Bionik LaboratoriesMyomo

Robotic Orthosis Devices

ReWalk RoboticsEkso BionicsCyberdyne

End-User Applications

Clinical RehabilitationHomecareIndustrial Exoskeletons

Robotic Orthosis Devices - Supply Chain

Use Cases of Robotic Orthosis Devices in Rehabilitative Therapy & Assisted Living

Rehabilitative Therapy : In rehabilitative therapy, robotic orthosis devices such as powered exoskeletons and gait trainers are used extensively in hospitals and rehab centers to support patients recovering from neurological injuries, strokes, spinal cord injuries, or orthopedic surgeries. These systems assist with repetitive limb movement practice, enhance muscle activation, and improve gait patterns, leading to better functional outcomes. Leaders like Ekso Bionics and ReWalk Robotics offer FDA‑cleared exoskeletons that facilitate intensive physical therapy and support evidence‑based neurorehabilitation programs, helping clinicians accelerate recovery and track progress with integrated software.

Sports Performance Enhancement : In sports performance enhancement, wearable robotic orthoses and supportive assistive devices are increasingly deployed to improve training quality, reduce injury risk, and support recovery for athletes. Lightweight powered braces and soft robotic supports help optimize movement mechanics, assist rehabilitation from ligament strains, and complement conventional strength and conditioning routines. High‑performance training centers and elite sports teams adopt these technologies to enable controlled movement assistance and adaptability during intensive training sessions, benefiting mobility, endurance, and balanced muscle engagement.

Assisted Living : For assisted living, robotic orthosis devices help older adults and individuals with mobility impairments maintain independence, daily activity function, and quality of life. Soft wearable supports and assistive exosuits enable safer ambulation, balance support, and fall prevention in home or care settings. Robotics companies are developing user‑friendly, ergonomic orthoses with intuitive controls and lighter structures tailored to daily use, expanding demand among aging populations and caregivers seeking reliable mobility aids outside clinical environments.

Recent Developments

Recent developments in the robotic orthosis devices market show intensified adoption of AI‑powered exoskeletons, wearable sensors, and IoT‑enabled rehabilitation systems that enhance motion tracking, adaptive assistance, and remote patient monitoring. A key trend is connected healthcare and tele‑rehabilitation, where data‑driven feedback and cloud‑based analytics support personalized therapy and improved clinical outcomes. This shift is strengthening links between rehabilitation robotics, patient engagement platforms, and digital health ecosystems, expanding use across hospitals, home care, and sports recovery programs.

December 2025 : Lifeward Ltd. announced a new distribution agreement with Verita Neuro, expanding access to the ReWalk Personal Exoskeleton in Mexico, Thailand, and the United Arab Emirates, with Verita Neuro set as the exclusive distributor, confirming the development and date.

June 2023 : Ekso Bionics received FDA clearance for its EksoNR robotic exoskeleton expanded indications to include multiple sclerosis patients, enhancing its application in neurological rehabilitation.

Impact of Industry Transitions on the Robotic Orthosis Devices Market

As a core segment of the Medical Device industry, the Robotic Orthosis Devices market develops in line with broader industry shifts. Over recent years, transitions such as Transition from Conventional to Robotic Orthosis and Integration of AI and IoT have redefined priorities across the Medical Device sector, influencing how the Robotic Orthosis Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Transition from Conventional to Robotic Orthosis

Currently, the global market for orthotic devices is undergoing a significant change. Rather than using passive orthotics to provide support, users are increasingly turning to robotic orthotic devices which not only offer support, but also interactive assistance, adaptive control and real time feedback. This technology is not only just used for treatment but also for enhancing athletic performance. Research in advanced robotic devices for medical rehabilitation is forecast to boost the market for robotic orthosis devices by approximately $1 million by 2030. These wearable exoskeleton systems and assistive orthotic technology options allow for patient centric rehabilitation methods and data driven therapy options. This has helped to enhance the innovation drive and commercial potential of the market. With a focus on outcomes, usability and long term benefits for patients the shift from traditional orthoses to robotic devices is crucial in driving the adoption of higher end products and subsequent revenue growth in this field.

Integration of AI and IoT

The integration of AI and IoT has transformed the robotic orthosis devices market by enabling personalized, real‑time performance adjustments that enhance patient rehabilitation outcomes. AI algorithms allow devices to adapt to an individual’s mobility needs, while IoT connectivity supports real-time monitoring, data synchronization, and integration with hospital systems. These advancements have expanded opportunities in the medical analytics sector, providing actionable insights for clinicians. Additionally, the rise of telemedicine and connected healthcare platforms has increased demand for intelligent orthoses in home-based therapy and remote rehabilitation programs, boosting adoption across rehabilitation centers, sports clinics, and assisted living facilities and driving innovation in wearable assistive technologies.